| Filed On | Filing |
|---|---|
| 08 Sep 2023 |
8-K/A: Submission of Matters to a Vote of Security Holders
At the 2023 Annual Meeting of Shareholders of the Company held on June 9, 2023, Regeneron’s shareholders voted, among other matters, on a proposal on the frequency of future advisory shareholder votes on executive compensation. As report... |
| 07 May 2019 |
8-K/A: Regulation FD Disclosure
The Company’s updated full year 2019 financial guidance consists of the following components: |
| 13 Sep 2017 |
8-K/A: Submission of Matters to a Vote of Security Holders
At the 2017 Annual Meeting of Shareholders of the Company held on June 9, 2017, Regeneron’s shareholders voted, among other matters, on a proposal on the frequency of future advisory shareholder votes on executive compensation. As report... |
| 23 May 2014 |
8-K/A: Unregistered Sales of Equity Securities
As described in Item 1.01 of this Report, which is incorporated herein by reference, on October 21, 2011, the Company issued $400 million aggregate principal amount of Notes to the Initial Purchaser in a private placement pursuant to exe... |
| 24 Jan 2012 |
8-K/A: Departure/Election of Directors or Officers; Compensation
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. |
| 22 Nov 2011 |
8-K/A: Other Events
Regeneron Announces FDA Approval of EYLEA™ (aflibercept) Injection for the Treatment of Wet Age-Related Macular Degeneration |
| 15 Sep 2011 |
8-K/A: Submission of Matters to a Vote of Security Holders
At Regeneron’s 2011 Annual Meeting of Shareholders held on June 10, 2011, Regeneron’s shareholders voted on, among other matters, a proposal on the frequency of future advisory shareholder votes on executive compensation. As reported by ... |
| 26 Jan 2001 |
8-K/A: Other Events
Tarrytown, New York, January 25, 2001 -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced its full year and fourth quarter financial and operating results for 2000. |
Loading...